Literature DB >> 20714179

Steroids and the management of macular edema.

Shani Golan1, Anat Loewenstein.   

Abstract

Macular edema (ME) is a condition which is usually secondary to an underlying disease process. It is most commonly seen following venous occlusive disease, diabetic retinopathy and posterior segment inflammatory disease. The treatment of ME varies, depending upon the underlying etiology, and has led to varying degrees of success. Traditionally, the main treatment options have included topical and systemic steroids, due to their known antiangiogenic, antiedematous, antiinflammatory and antiproliferative effects. This comprehensive review outlines the current use of steroids and highlights the ever-growing indications for steroids in ME secondary to various ocular conditions as well as the recent breakthrough results of the efficacy of this treatment. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714179     DOI: 10.1159/000315159

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  2 in total

1.  Intravitreal Corticosteroids in the Management of Diabetic Macular Edema.

Authors:  Stephen G Schwartz; Harry W Flynn; Ingrid U Scott
Journal:  Curr Ophthalmol Rep       Date:  2013-09

2.  Comparison of the intraocular pressure following an intravitreal triamcinolone acetonide injection for diabetic macula oedema in vitrectomised and non-vitrectomised eyes.

Authors:  Yusuke Orii; Makoto Gozawa; Yoshihiro Takamura; Yuko Takeuchi; Masakazu Morioka; Yutaka Yamada; Takehiro Matsumura; Masahiko Sugimoto; Masaru Inatani
Journal:  BMJ Open Ophthalmol       Date:  2021-01-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.